The authors retrospectively reviewed the characteristics and outcomes of adult patients with relapsed/refractory large B-cell lymphoma treated with Standard of care axicabtagene ciloleucel or tisagenlecleucel .
[Haematologica]
Sorry, but the selected Zotpress account can't be found.